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Iowa Mutant Apolipoprotein 
A-I (ApoA-IIowa) Fibrils Target 
Lysosomes
Hirokazu Kameyama1,*, Hiroyuki Nakajima1,*, Kazuchika Nishitsuji2, Shiho Mikawa1,3, 
Kenji Uchimura4, Norihiro Kobayashi5, Keiichiro Okuhira1, Hiroyuki Saito3 & Naomi Sakashita2
The single amino acid mutation G26R in human apolipoprotein A-I (apoA-IIowa) is the first mutation 
that was associated with familial AApoA1 amyloidosis. The N-terminal fragments (amino acid residues 
1–83) of apoA-I containing this mutation deposit as amyloid fibrils in patients’ tissues and organs, but 
the mechanisms of cellular degradation and cytotoxicity have not yet been clarified. In this study, 
we demonstrated degradation of apoA-IIowa fibrils via the autophagy-lysosomal pathway in human 
embryonic kidney 293 cells. ApoA-IIowa fibrils induced an increase in lysosomal pH and the cytosolic 
release of the toxic lysosomal protease cathepsin B. The mitochondrial dysfunction caused by apoA-IIowa 
fibrils depended on cathepsin B and was ameliorated by increasing the degradation of apoA-IIowa 
fibrils. Thus, although apoA-IIowa fibril transport to lysosomes and fibril degradation in lysosomes may 
have occurred, the presence of an excess number of apoA-IIowa fibrils, more than the lysosomes could 
degrade, may be detrimental to cells. Our results thus provide evidence that the target of apoA-IIowa 
fibrils is lysosomes, and we thereby gained a novel insight into the mechanism of AApoA1 amyloidosis.
Apolipoprotein A-I (apoA-I), the major protein in high-density lipoproteins, plays a critical role in lipid 
metabolism by transporting excess cellular cholesterol from the peripheral tissues to the liver1. ApoA-I 
contains 11/22-mer tandem repeats that have a high tendency to form amphipathic α -helices, which have 
lipid-binding activity2. About 50% of the apoA-I secondary structure consists of α -helices, and its N-terminus 
comprises an α -helix bundle3,4. Some apoA-I mutants are associated with the hereditary amyloidosis called 
AApoA1 amyloidosis5. As of today, 19 mutations have been associated with AApoA1 amyloidosis6. One of these 
mutations, a G26R single substitution (herein referred to as the Iowa mutation), is the first mutation that was 
determined to be associated with AApoA1 amyloidosis7,8. This mutation facilitates proteolysis of apoA-I, and 
the resulting N-terminal fragments (amino acid residues 1–83) of the variant apoA-I deposit as amyloid fibrils 
in various organs, such as the kidney, liver, and heart6,7,9. In protein misfolding diseases such as amyloidosis, 
protein aggregates that accumulate or deposit in organs and tissues are abnormally folded; these aggregates 
are formed by aberrant production of precursor proteins or disturbances in the intracellular or extracellular 
protein degradation pathways10,11. The mechanism by which these apoA-I variants can form amyloid fibrils is 
not fully understood. Small intermediates or soluble oligomers that are found during the aggregation process 
are synaptotoxic or cytotoxic in some protein misfolding diseases such as Alzheimer’s disease, Parkinson’s 
disease, and Huntington’s disease12, and amyloid fibrils are also reportedly cytotoxic13. We previously showed 
that cellular interactions with and cytotoxicity of apoA-I fibrils depended on the sulfate moieties of heparan 
sulfate on the cell surface14, but the mechanisms of cellular degradation and cytotoxicity of apoA-I fibrils remain 
to be elucidated.
Since discovery of lysosomes in the early 1950 s, they have been shown to be involved in various lysosomal 
storage diseases and other human diseases such as cancer, obesity, and neurodegeneration15,16. With regard to 
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amyloidosis, Liu et al. reported that amyloid β (Aβ ) that has accumulated in lysosomes destabilizes the lysosomal 
membrane and induces neurotoxicity17. Another study suggested that β 2-microglobulin amyloid fibrils accu-
mulated in lysosomes in a neuroblastoma cell line and disrupted lysosomal membrane protein trafficking and 
lysosomal degradation of proteins18.
Macroautophagy (referred to here as autophagy) is a cellular protein degradation system for long-lived pro-
teins and organelles19. Autophagy includes a number of steps: sequestration, transport or fusion to lysosomes, 
degradation, and reuse of degradation products. During degradation, autophagosome components that formed 
during the first step of autophagy are degraded by lysosomal hydrolases20. Thus, clearance of autophagosomes 
depends on lysosomal function21. Autophagy has also been implicated in clearance of various amyloidogenic 
proteins. For example, recent studies showed that autophagy played a critical role in degradation of human islet 
amyloid polypeptide (IAPP) and protected β -cells against cytotoxicity of IAPP22–24. Lysosome-dependent dysreg-
ulation of autophagy was also suggested to underlie cardiomyopathy pathogenesis in amyloidogenic light chain 
amyloidosis25.
Here, we used cell-based assays to investigate the role of lysosomes and autophagy in cellular degradation 
and cytotoxicity of G26R apoA-I fibrils (apoA-IIowa fibrils). ApoA-IIowa fibrils were degraded via the 
autophagy-lysosomal pathway in human embryonic kidney (HEK) 293 cells, which resulted in a loss of lysosomal 
acidity and in the cytosolic release of the lysosomal protease cathepsin B. The mitochondrial dysfunction caused 
by apoA-IIowa fibrils was reversed by enhancing the degradation of apoA-IIowa fibrils and inhibiting cathepsin 
B. Our results thus emphasize the importance of autophagy and lysosomes in the pathology of AApoA1 
amyloidosis.
Results
ApoA-IIowa fibrils were degraded in an autophagy- and lysosome-dependent manner. We first 
determined whether apoA-IIowa fibrils were degraded in cultured cells. As previously reported, the 1–83 fragments 
of wild-type (WT) apoA-I formed fibrils and these fibrils were cytotoxic14,26. However, amyloid fibrils of WT 
apoA-I are reportedly associated with atherosclerotic plaques27, not with hereditary AApoA1 amyloidosis. In the 
present study, we focused on the pathological effect of amyloid fibrils of the Iowa mutant of apoA-I. As shown in 
Supplementary Fig. S1a, the fibril content of the apoA-IIowa fibrils preparation that were used in the present study 
was more than 90%. One of the authors also reported that apoA-IIowa fibrils were positive for thioflavin T and 
consisted of long and straight fibrils having heights of 5 to 10 nm as revealed by the atomic force microscopy26. 
ApoA-IIowa fragments without incubation at 37 °C (i. e., freshly solubilized apoA-IIowa fragments) showed no 
cytotoxicity in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Supplementary 
Fig. S1b), which enabled us to exclude a possibility of cytotoxicity of non-fibrillar apoA-IIowa fragments. HEK293 
cells were incubated with apoA-IIowa fibrils for 12 h, washed 3 times with Dulbecco’s modified Eagle’s medium 
(DMEM), and cultured for additional tme periods (0, 6, 12, 24 h). Cells were fixed, permeabilized, and stained 
with an anti-apoA-I antibody. As Fig. 1a shows, cells incubated with apoA-IIowa fibrils for 12 h demonstrated 
robust apoA-I staining, which indicates that apoA-IIowa fibrils interacted with HEK293 cells. Signals from apoA-
IIowa fibrils disappeared 6–24 h after cells were washed with PBS, in a time-dependent manner. These results 
suggest that HEK293 cells degraded the apoA-IIowa fibrils. Results of dot blotting confirmed that apoA-I fibrils 
were almost completely degraded during the additional culture period (Fig. 1b). Because previous reports 
showed that Aβ was degraded by lysosomes28,29, we analyzed the effect of chloroquine on cellular degradation of 
apoA-IIowa fibrils. Chloroquine is a weak base and reportedly impaired functions of acidic organelles, including 
lysosomes, by means of neutralization30. As seen in Fig. 1c, cellular degradation of apoA-IIowa fibrils was reduced 
to approximately 10% in the presence of chloroquine. Thus, it was indicated that apoA-IIowa fibrils were degraded 
via the lysosomal pathway.
Given the finding that protein aggregates or inclusion bodies within cells were cleared by a certain type of 
autophagy termed aggrephagy31, we then studied whether apoA-IIowa fibrils were degraded via the autophagy 
pathway. 3-Methyladenine (3-MA) inhibits the activity of class III phosphatidylinositol 3-kinase, which plays 
an essential role in the biogenesis of autophagosomes, and thereby interrupts autophagy32. When autophagy 
was inhibited by adding 3-MA, degradation of apoA-IIowa fibrils was almost completely suppressed (Fig. 1d). 
Rapamycin (sirolimus) is a macrocyclic antibiotic made by the bacterium Streptomyces hygroscopicus, which 
occurs in the soil of Easter Island. Rapamycin inhibits the mechanistic target of rapamycin (serine/threonine 
kinase) complex 1 and thus induces autophagy33. In contrast to the effect of 3-MA, rapamycin markedly facili-
tated the degradation of apoA-IIowa fibrils (Fig. 1e). These findings indicate that degradation of apoA-IIowa fibrils 
occurred in an autophagy-lysosomal pathway-dependent fashion in cultured cells.
Transcription factor EB (TFEB) enhanced degradation of apoA-IIowa fibrils. Sardiello et al. 
reported that TFEB induced lysosomal biogenesis and increased degradation of pathogenic proteins such as the 
polyglutamine-expanded huntingtin protein, which causes Huntington’s disease34. Because apoA-IIowa fibrils 
appeared to be degraded in lysosomes, we questioned whether increasing lysosomes by overexpressing TFEB 
would enhance degradation of apoA-IIowa fibrils. We transfected HEK293 cells with pEGFP-N1-TFEB before 
treating cells with apoA-IIowa fibrils. By means of immunoblotting with an anti-lysosomal-associated membrane 
protein 2 (LAMP2) (Supplementary Fig. S2), which is a lysosome marker35, we confirmed that TFEB overex-
pression increased the number of lysosomes. As Fig. 1f illustrates, degradation of apoA-IIowa fibrils was greatly 
(approximately two times) enhanced in TFEB-transfected cells. These results suggest that TFEB overexpression 
facilitated apoA-IIowa fibril degradation by increasing the number of lysosomes.
Effects of dynamin and actin dynamics on cell interactions with apoA-IIowa fibrils. The 
above-described results showing that apoA-IIowa fibrils were degraded via the autophagy-lysosomal pathway 
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strongly suggested that apoA-IIowa fibrils were internalized by cells and transported to lysosomes. Thus, we stud-
ied the internalization pathway of apoA-IIowa fibrils by using HEK293 cells and inhibitors of different types of 
endocytosis. Inasmuch as many endocytosis pathways depend on actin dynamics36, we also used cytochalasin D, 
Figure 1. ApoA-IIowa fibrils were degraded via the autophagy-lysosomal pathway. (a) HEK293 cells were 
plated on poly-L-lysine-coated cover glasses and treated with apoA-IIowa fibrils (1 μ M) at 37 °C for 12 h. 
Cells were washed with fresh DMEM and then incubated in DMEM at 37 °C for 0, 6, 12, or 24 h. ApoA-
IIowa fibrils were visualized by using an anti-apoA-I antibody and an Alexa Fluor 568-conjugated secondary 
antibody. (b) HEK293 cells were treated with apoA-IIowa fibrils (1 μ M) at 37 °C for 12 h. Cells were washed 
with fresh DMEM and then incubated in DMEM for 6 h, after which whole cell lysates were prepared. The 
apoA-I contents of the whole cell lysates were analyzed by means of dot blotting. β -Actin was used as a 
loading control. The graph shows quantification of cellular apoA-IIowa fibrils. Data are means ± SE of three 
independent experiments. (c,d,e) HEK293 cells were plated and treated with 1 μ M apoA-IIowa fibrils for 12 h. 
Cells were washed with fresh DMEM and cultured at 37 °C for an additional 6 or 12 h in fresh DMEM in the 
presence or absence of chloroquine (c; 50 μ g/mL, 12 h), 3-MA (d; 0.75 μ g/mL, 12 h), or rapamycin (e; 2.5 μ M, 
6 h), after which whole cell lysates were prepared. The apoA-I contents of the whole cell lysates were analyzed 
by using dot blotting. β -Actin was used as a loading control. (f) Effects of TFEB overexpression on cellular 
degradation of apoA-IIowa fibrils. HEK293 cells were plated, transfected with pEGFP-N1-TFEB or an empty 
vector, and cultured at 37 °C for 48 h. Cells were treated with 1 μ M apoA-IIowa fibrils for 12 h, washed with 
fresh DMEM, and incubated for 12 h, after which whole cell lysates were prepared. The apoA-I contents in 
whole cell lysates were analyzed by dot blotting with an anti-apoA-I antibody. β -Actin was used as a loading 
control. The graphs show quantification of the degraded fibrils. Data are means ± SE of three independent 
experiments. * p = 0.0013 (c), 0.011 (d), 0.017 (e), and 0.032 (f) versus each drug or TFEB (−) cells.
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which inhibits actin dynamics-dependent endocytosis by disrupting actin polymerization37. Dynasore is 
a small molecule that inhibits dynamin 2, which is essential for endocytic vesicle formation in clathrin- and 
caveolin-mediated endocytosis, as well as clathrin- and caveolin-independent endosytosis38. Nystatin disrupts 
caveolae formation by binding to sterols and thus inhibits caveolin-mediated endocytosis. Cytochalasin D and 
dynasore, but not nystatin, reduced the content of apoA-IIowa fibrils in HEK293 cells by 40–50% after incubation 
(Fig. 2). These results suggest that dynamin and actin dynamics were involved in internalization of apoA-IIowa 
fibrils.
ApoA-IIowa fibrils induced lysosomal and mitochondrial dysfunction. Because some amyloid fibrils 
reportedly interfered with lysosomal function18,25 and our data strongly suggested that apoA-IIowa fibrils were 
transported to lysosomes, we investigated whether apoA-IIowa fibrils would affect lysosomal function. We used 
LysoSensor, a pH-sensitive fluorescent dye, to assess lysosomal pH. Consistent with our previous study with 
Chinese hamster ovary cells14, the numbers of acidic compartments including lysosomes decreased in HEK293 
cells treated with apoA-IIowa fibrils (Fig. 3a), which suggests that apoA-IIowa fibrils caused a reduction in lysosomal 
acidity.
We also previously showed that apoA-IIowa fibrils caused increased production of reactive oxygen species 
(ROS)39. Lysosomal membrane permeabilization and subsequent cytosolic release of lysosomal protease may 
lead to a loss of mitochondrial membrane potential and ROS production40. We found, as Fig. 3b illustrates, that 
apoA-IIowa fibrils induced a loss of mitochondrial polarization in HEK293 cells. These findings, together with 
Figure 2. Effects of endocytic inhibition on cellular uptake of apoA-IIowa fibrils. HEK293 cells were plated 
and treated with 1 μ M apoA-IIowa fibrils for 12 h in the presence or absence of cytochalasin D (1 μ M), dynasore 
(15 μ M), or nystatin (50 μ g/mL), after which whole cell lysates were prepared. The apoA-I contents in the lysates 
were analyzed by using dot blotting. β -Actin was used as a loading control. The graphs show quantification of 
cellular apoA-IIowa fibrils. Data are means ± SE of three independent experiments. * p = 0.0002 (cytochalasin D) 
and 0.0098 (dynasore) versus each drug (−) cells.
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results showing that apoA-IIowa fibrils were transported to lysosomes and caused lysosomal dysfunction, indicated 
the possibility that apoA-IIowa fibrils caused lysosomal membrane permeabilization.
Cathepsin B is a cysteine cathepsin41 that stimulates ROS production and has a role in the loss of mitochon-
drial inner membrane potential after its release into cytosol42. We thus evaluated whether apoA-IIowa fibrils would 
induce cytosolic release of cathepsin B. Figure 3c shows that cathepsin B in the cytosolic fraction increased in 
cells that were treated with apoA-IIowa fibrils, which suggests that apoA-IIowa fibrils induced leakage of lysosomal 
cathepsin B into the cytosol. As shown in Supplementary Fig. S3, we did not observed TUNEL (terminal deoxy-
nucleotidyl transferase dUTP nick end labeling) positive cells in apoA-IIowa fibril-treated cells.
Rescue of HEK293 cells from cytotoxicity of apoA-IIowa fibrils. We also investigated whether 
enhancement of degradation of apoA-IIowa fibrils would rescue cells that were damaged by the fibrils. Because 
rapamycin facilitated degradation of apoA-IIowa fibrils, we incubated cells in the presence of rapamycin and 
assessed mitochondrial dysfunction. Rapamycin lessened the mitochondrial dysfunction caused by treating cells 
with apoA-IIowa fibrils (Fig. 4a). Next, to investigate that release of cathepsin B into the cytosol was responsible for 
Figure 3. ApoA-IIowa fibrils induced lysosomal dysfunction, mitochondrial depolarization, and cytosolic 
release of cathepsin B. (a) HEK293 cells were plated on poly-L-lysine-coated cover glasses and treated with 
1 μ M apoA-IIowa fibrils at 37 °C for 6 h. The number of acidic organelles was assessed by using LysoSensor 
dye. Representative images of acidic signals (red) and differential interference contrast (DIC) microscopy 
are shown. The graph shows quantified LysoSensor signals. Data are means ± SE of three independent 
experiments. * * p = 0.0093 versus non-treated cells. (b) Mitochondrial membrane potential was analyzed by 
using TMRE fluorescent dye, after treatment with 1 μ M apoA-IIowa fibrils for 12 h. Representative images of 
TMRE fluorescence (red) and DIC microscopy are shown. The graph shows quantified TMRE signals. Data 
are means ± SE of three independent experiments. * p = 0.016 versus non-treated cells. (c) The lysosomal and 
cytosolic fractions of HEK293 cells that had been treated with 1 μ M apoA-IIowa fibrils for 6 h were subjected to 
Western blotting with an anti-cathepsin B antibody to assess cytosolic release of cathepsin B. β -Actin was used 
as a loading control. The data represent two independent experiments.
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mitochondrial depolarization, we treated cells with CA-074, which is a cathepsin B inhibitor43, after treating them 
with apoA-IIowa fibrils. The additional treatment with CA-074 ameliorated the apoA-IIowa fibril-induced mito-
chondrial dysfunction (Fig. 4b), which suggests that activity of cytosolic cathepsin B contributed to apoA-IIowa 
fibril-induced mitochondrial dysfunction.
ApoA-IIowa fibrils impaired autophagic clearance. The p62 protein sequestosome 1 is a 
ubiquitin-binding scaffold protein and also binds to LC3, microtubule-associated protein 1 light chain 3, which is 
a specific autophagy effector44. p62 is an autophagy adaptor molecule and is used as a marker of autophagic flux, 
inasmuch as p62 is degraded in the autolysosome, which is a product of direct fusion of an autophagosome and a 
lysosome45. Because apoA-IIowa fibrils caused a loss of lysosomal acidity, we evaluated whether lysosomal activity 
also decreased, which would lead to accumulation of p62. As Fig. 5a shows, apoA-IIowa fibrils induced an increase 
in p62 protein level. Immunocytochemistry demonstrated swollen p62-positive puncta in apoA-IIowa fibril-treated 
cells (Fig. 5b). These data, together with findings that apoA-IIowa fibrils induced lysosomal dysfunction, suggest 
that apoA-IIowa fibrils impaired clearance of p62 protein by interfering with lysosomal proteolytic activity. A sum-
mary of our findings is shown in Fig. 6.
Discussion
The lysosomal pathway has been shown to have an important role in degradation of protein aggregates including 
those of α -synuclein, tau, and mutant huntingtin proteins46 as well as IAPP22–24. Autophagy has been implicated 
in the clearance of protein aggregates in neurodegenerative diseases47,48. In the present study, degradation of 
apoA-IIowa fibrils occurred via the autophagy-lysosomal pathway. Upregulation of lysosomal biogenesis by TFEB 
overexpression facilitated this degradation. Furthermore, apoA-IIowa fibrils induced lysosomal membrane per-
meabilization and a loss of lysosomal acidity. Thus, although apoA-IIowa fibrils were degraded in lysosomes, the 
presence of an excess number of apoA-IIowa fibrils in the lysosomes, more than the lysosomes could degrade, may 
be detrimental to the lysosomes. As p62 was accumulated in the apoA-IIowa fibrils-treated cells, it is also suggested 
that the proteolytic capacity of the lysosomes was disturbed. One study showed that inhibition of mammalian 
Figure 4. Rapamycin and an inhibitor of cathepsin B improved mitochondrial depolarization induced by 
apoA-IIowa fibrils. HEK293 cells were plated on poly-L-lysine-coated cover glasses and treated with 1 μ M  
apoA-IIowa fibrils at 37 °C for 12 h (a) in the presence or absence of rapamycin (2.5 μ M) or (b) in the presence or 
absence (vehicle) of an inhibitor of cathepsin B (CA-074, 1 μ M) for 6 h for recovery from the cytotoxicity of apoA-
IIowa fibrils, after which mitochondrial membrane potential was analyzed by using TMRE dye. Representative 
images of TMRE fluorescence (red) and DIC microscopy are shown. The graphs show quantification of TMRE 
signals. Data are means ± SE of three independent experiments. Where no bars appear in the graphs, experimental 
values were between 0 and 0.013. (a) * * * p = 0.00032 versus cells treated with apoA-IIowa fibrils. (b) * * * p = 0.000070 
versus apoA-IIowa fibrils for 12 h or vehicle for 6 h.
www.nature.com/scientificreports/
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target of rapamycin, mTOR, resulted in induction of defective autophagy and exacerbated neurodegenerative 
phenotypes in amyotrophic lateral sclerosis49. In contrast, Guan et al. showed that targeting mTOR by rapamycin 
protected cardiomyocytes against amyloidogenic light chain proteotoxicity25. In agreement with this finding, 
our study here demonstrated that rapamycin reduced mitochondrial dysfunction induced by apoA-IIowa fibrils. 
All these data suggest that the autophagy-lysosomal pathway plays a critical role in the clearance of apoA-I 
fibrils and that targeting of autophagy and lysosomes may be an attractive strategy for treatment of AApoA1 
Figure 5. ApoA-IIowa fibrils inhibited autophagic flux in HEK293 cells. (a) HEK293 cells were plated and 
treated with 1 μ M apoA-IIowa fibrils at 37 °C for 12 h, after which whole cell lysates were prepared. The lysates 
were subjected to Western blotting with an anti-p62 antibody. β -Actin was used as a loading control. The graph 
shows quantification of p62. Data are means ± SE of three independent experiments. * p = 0.042 versus non-
treated cells. (b) Cells were plated on poly-L-lysine-coated cover glasses and treated with 1 μ M apoA-IIowa fibrils 
at 37 °C for 12 h. After cells were fixed, they were stained with an anti-p62 antibody, followed by an Alexa Fluor 
488-conjugated secondary antibody. DAPI counterstaining appears blue.
Figure 6. A possible mechanism of the cytotoxicity of apoA-IIowa fibrils. ApoA-IIowa fibrils were internalized 
and transported to the lysosomes, and some portions of them were degradable in the lysosomes. However, 
the presence of an excess amount of apoA-IIowa fibrils in the lysosomes caused a loss of lysosomal acidity and 
cytosolic release of cathepsin B followed by mitochondrial depolarization.
www.nature.com/scientificreports/
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amyloidosis. Jakhria et al. reported that fragmented amyloid fibrils of β 2-microglobulin accumulated in lysosomes 
and impaired their proteolytic ability without causing an increase in lysosomal pH18, whereas amyloidogenic 
light chain proteins impaired autophagic flux by increasing lysosomal pH and subsequently interfering with the 
proteolytic ability of the lysosomes25. In the present study, an overload of lysosomes with apoA-IIowa fibrils as well 
as an increase in lysosomal pH may contribute to impaired lysosomal proteolytic activity.
We previously showed that apoA-IIowa fibrils inhibited the reduction of 3-(4,4-dimethylthiazol-2-yl)-2,5-diph
enyltetrazolium bromide (MTT) and induced ROS production14,39. Also, apoA-IIowa fibrils induced mitochondrial 
depolarization14. These results suggested that apoA-IIowa fibrils acted, directly or indirectly, on mitochondria. Our 
results showing that apoA-IIowa fibrils were transported to lysosomes and induced increased lysosomal acidity 
also suggest that apoA-IIowa fibrils may act on lysosomes from the inside. Thus, apoA-IIowa fibrils induced cytosolic 
release of the lysosomal protease cathepsin B, which is reportedly responsible for mitochondrial depolarization42. 
Indeed, mitochondrial depolarization induced by apoA-IIowa fibrils was rescued by treating cells with a cathepsin 
B inhibitor. A previous study has shown that Aβ 42 induced lysosomal membrane damage and cytosolic release of 
lysosomal contents in cultured cell17. Our results indicate that lysosomal dysfunction and cytosolic release of lyso-
somal contents are also crucial for cytotoxicity of apoA-IIowa fibrils. How apoA-IIowa fibrils induce lysosomal mem-
brane damage is currently unknown. Milanesi et al. reported that amyloid fibrils formed from β 2-microglobulin 
interacted strongly with and disrupted lipid bilayers50, and disruption of membranes was enhanced in acidic pH51. 
One of the authors of the present study recently reported that formation of apoA-IIowa fibrils was promoted on a 
lipid membrane, which suggests that apoA-IIowa fibrils may interact with lipid bilayers52. Thus, apoA-IIowa fibrils 
may interact with and disrupt the lysosomal membrane in a manner similar to that of β 2-microglobulin amyloid 
fibrils. As we did not observed cell death in apoA-IIowa fibril-treated cells, we ruled out a possibility that cytosolic 
release of lysosomal cathepsin B was due to cell death. Although ROS production was linked to mitochondrial 
depolarization53,54 and oxidative stress induced lysosomal labilization55, our results indicate that the primary 
inducer of mitochondrial dysfunction in apoA-IIowa fibril-treated cells was lysosomal membrane permeabiliza-
tion. Lysosomal membrane permeabilization may also contribute to the loss of lysosomal acidity.
TFEB is a basic helix-loop-helix leucine zipper transcription factor and was identified as a master regulator of 
lysosomal genes including LAMP1, LAMP2, cathepsins, and subunits of vacuolar ATPases34. TFEB overexpres-
sion in cultured cells increased lysosomal biogenesis and enhanced clearance of pathogenic protein aggregates 
formed by the mutant huntingtin protein34. Astrocytic expression of TFEB reportedly facilitated Aβ clearance 
and attenuated amyloid plaque formation in a mouse model of Alzheimer’s disease56. In our study here, TFEB 
overexpression promoted degradation of apoA-IIowa fibrils. Thus, activation of lysosomal biogenesis may be a 
potential therapeutic target and enhance cell clearance of protein aggregates in neurodegenerative diseases as 
well as amyloidosis.
Pinocytosis-dependent and dynamin-dependent endocytoses were implicated in the internalization and 
cytotoxicity of β 2-microglobulin amyloid fibrils18,57. In the present study, cytochalasin D and dynasore inhib-
ited degradation of apoA-IIowa fibrils, whereas nystatin did not. Cytochalasin D and nystatin are inhibitors of 
endocytosis that depends on actin dynamics and caveolae formation, respectively36,38. Dynasore is an inhibitor 
of the GTPase activity of dynamin, which is a regulator of membrane fission and indispensable for clathrin- and 
caveolin-mediated endocytosis, as well as clathrin- and caveolin-independent endocytosis37. Thus, our results 
suggest that apoA-IIowa fibrils may be internalized by cells and transported to lysosomes in a dynamin- and actin 
dynamics-dependent, but caveolin-independent, manner. Similarly, dynasore and cytochalasin D reportedly 
reduced the cytotoxicity of β 2-microglobulin amyloid fibrils, possibly by inhibiting fibril internalization18,57. 
Nonphagocytic cells internalized beads having a diameter of 5.5 μ M in a clathrin- and dynamin-dependent 
fashion58. Given that some types of pinocytosis depend on dynamin36, apoA-IIowa fibrils may be internalized via 
pinocytosis and/or dynamin-dependent endocytosis. Elucidating the detailed mechanisms of internalization and 
intracellular transport of amyloid fibrils is an important challenge for the future.
In summary, we showed that apoA-IIowa fibrils were degraded via the autophagy-lysosomal pathway and 
induced lysosomal and mitochondrial dysfunction. Degradation of apoA-IIowa fibrils was facilitated by enhancing 
autophagy and lysosomal biogenesis, and cytotoxicity of apoA-IIowa fibrils was consequently ameliorated. These 
results indicate that enhancing the degradation of apoA-IIowa fibrils may be a therapeutic strategy. Although addi-
tional studies are needed to confirm the role of the autophagy-lysosomal pathway in clearance of apoA-I fibrils 
in vivo, our findings support the importance of the autophagy-lysosomal pathway in the pathogenesis and pathol-
ogy of amyloidosis and provide a new insight into the development of AApoA1 amyloidosis treatment.
Materials and Methods
Materials. Chloroquine was purchased from Wako Pure Chemical Industries (Osaka, Japan). 3-MA, rapa-
mycin, and dynasore were purchased from Cayman Chemical (Ann Arbor, MI). A polyclonal anti-p62 antibody 
was purchased from Cell Signaling Technology, Inc. (Beverly, MA), a polyclonal anti-β -actin antibody was from 
Sigma (St. Louis, MO), and a polyclonal anti-LAMP2 antibody was from Bioss Antibodies (Woburn, MA). An 
inhibitor of cathepsin B (CA-074) was purchased from Peptide Institute, Inc. (Osaka, Japan). Nystatin and cyto-
chalasin D were purchased from Sigma. A monoclonal anti-apoA-I antibody (Wt20-7) was produced as previ-
ously described14. pEGFP-N1-TFEB was a gift from Shawn Ferguson (Addgene plasmid #38119)59.
Preparation of apoA-I proteins. cDNA that encodes the N-terminal fragment (amino acid residues 1–83) 
of apoA-I was obtained by using PCR methods in which full-length human apoA-I cDNA was used as the tem-
plate. A mutation to create the G26R variant was introduced into the cDNA encoding the N-terminus of apoA-I 
(amino acid residues 1–83) by using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). 
The cDNA was ligated into the pET32a+ expression vector (Novagen, Madison, WI), after which the con-
struct was transformed into Escherichia coli strain BL21 Star (DE3) (Thermo Fisher Scientific, Waltham, MA). 
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The apoA-I fusion proteins were expressed and purified as previously described4. The apoA-I preparations 
were at least 95% pure, as determined by means of sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) followed by staining with Coomassie Brilliant Blue. The apoA-I preparations were lyophilized and 
stored at − 20 °C before use.
Preparation of apoA-I fibrils. The N-terminal fragment (amino acid residues 1–83) of apoA-I carrying the 
Iowa mutation was solubilized in 6 M guanidine hydrochloride in phosphate-buffered saline (PBS) and dialyzed 
into PBS. The peptide solution obtained was diluted with PBS to give a final concentration of 0.3 mg/mL, and the 
solution was incubated in a microcentrifugation tube in a rotating mixer at 37 °C for 7 days. Fibril formation of 
the apoA-IIowa fragments were monitored by measuring fluorescence of thioflavin T (10 μ M) at 485 nm with an 
excitation wavelength of 445 nm.
Cell culture. HEK293 cells were cultured in DMEM (Sigma) supplemented with 10% heat-inactivated fetal 
bovine serum (BIOWEST SAS, Nuaillé, France), 100 U/mL penicillin (Sigma), and 100 μ g/mL streptomycin 
(Sigma) at 37 °C in an atmosphere containing 5% CO2.
Assay of cellular degradation of apoA-IIowa fibrils by using dot blotting and immunocytochemistry. 
Cells were plated on 6-well culture plates and cultured for 12 h. Cells were then incubated with 1 μ M apoA-IIowa 
fibrils at 37 °C for 12 h, followed by an additional incubation in fresh DMEM with or without inhibitors or induc-
ers of lysosomes and autophagy. In some experiments, cells were transfected with the pEGFP-N1 plasmid con-
taining human TFEB cDNA by using the ViaFect Transfection Reagent (Promega Corporation, Fitchburg, WI) 
and were cultured for 48 h before treatment with apoA-IIowa fibrils. After incubation, whole cell lysates were pre-
pared by trichloroacetic acid precipitation and apoA-I contents were analyzed by using dot blotting as previously 
described14. Briefly, cells were washed 3 times with PBS and then treated with 10% trichloroacetic acid (w/v) in 
PBS. After incubation on ice for 30 min, the samples were centrifuged at 1,000 × g for 5 min at 4 °C. Resultant 
precipitates were dissolved in SDS-PAGE sample buffer [0.125 M Tris-HCl, 4% (w/v) SDS, 20% (v/v) glycerol, and 
0.01% (w/v) bromophenol blue] for preparation of whole cell lysates. The whole cell lysates obtained were blotted 
on nitrocellulose membranes (Pall Corporation, Port Washington, NY). ApoA-IIowa fibrils on the membranes 
were probed with an anti-apoA-I antibody followed by a horseradish peroxidase-labeled anti-mouse antibody 
(Cell Signaling Technology, Inc.) and ImmunoStar LD (Wako Pure Chemical Industries). Protein contents of cell 
lysates were normalized to the expression level of β -actin protein. Signals were visualized and analyzed by using 
an LAS-3000 luminescent image analyzer (Fujifilm, Tokyo, Japan).
For immunocytochemistry, cells were plated on a poly-L-lysine-coated cover glass and cultured overnight. 
They were then incubated with 1 μ M apoA-IIowa fibrils at 37 °C for 12 h, after which they were washed with 
fresh DMEM and cultured in DMEM for an additional 6–24 h. The cells were fixed with 4% paraformaldehyde 
in PBS at room temperature for 20 min. After the cells were washed 3 times with PBS, they were blocked and 
permeabilized with 10% normal goat serum and 0.05% saponin in PBS at room temperature for 20 min. They 
were then incubated with an anti-apoA-I antibody followed by Alexa Fluor 568-conjugated secondary antibody 
(Thermo Fisher Scientific). The stained specimens were mounted with Vectashield mounting medium containing 
4ʹ ,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc., Burlingame, CA) and examined with an A1R 
confocal laser microscope (Nikon Corporation, Tokyo, Japan).
Assay of the internalization pathway of apoA-IIowa fibrils via dot blotting. HEK293 cells were 
plated on 6-well culture plates and treated with 1 μ M apoA-IIowa fibrils at 37 °C for 12 h in the presence or absence 
of cytochalasin D (1 μ M), dynasore (15 μ M), or nystatin (50 μ g/mL). Whole cell lysates were prepared and the 
apoA-I contents of the lysates were analyzed by using dot blotting as described above.
Analysis of autophagic flux via Western blotting and immunocytochemistry. Briefly, for Western 
blotting with an anti-p62 antibody, cells were plated on 6-well culture plates and treated with 1 μ M apoA-IIowa 
fibrils at 37 °C for 12 h, after which whole cell lysates were prepared and subjected to Western blotting with an 
anti-p62 antibody, as described above.
For immunocytochemistry, cells were plated on a poly-L-lysine-coated cover glass and cultured overnight. 
The cells were then incubated with 1 μ M apoA-IIowa fibrils at 37 °C for 12 h, washed with PBS, and fixed with 4% 
paraformaldehyde in PBS at room temperature for 20 min. After the cells were washed 3 times with PBS, they 
were blocked and permeabilized with 10% normal goat serum and 0.05% saponin in PBS at room temperature for 
20 min. The cells were then incubated with an anti-p62 antibody followed by Alexa Fluor 488-conjugated second-
ary antibody (Thermo Fisher Scientific). Stained specimens were mounted with Vectashield mounting medium 
containing DAPI and examined with an A1R confocal laser microscope.
Measurement of mitochondrial membrane potential. Mitochondrial membrane potential was deter-
mined by using the mitochondrial membrane potential-sensitive fluorophore tetramethylrhodamine ethyl ester 
(TMRE) (MitoPT assay kit; ImmunoChemistry Technologies, Bloomington, MN). Briefly, HEK293 cells were 
plated and cultured on a poly-L-lysine-coated cover glass, followed by treatment with 1 μ M apoA-I fibrils at 37 °C 
for 12 h. After the cells were washed 3 times with PBS, they were treated with TMRE (10 nM) at 37 °C for 20 min 
in the dark. TMRE fluorescence was acquired by using an excitation wavelength of 555 nm with an LSM 710 con-
focal microscope (Carl Zeiss MicroImaging GmbH, Jena, Germany). For quantification, images were analyzed by 
using ImageJ software (NIH, Bethesda, MD).
Assessment of lysosomal pH. Lysosomal pH was analyzed by means of LysoSensor Yellow/Blue DND-160 
(Thermo Fisher Scientific) as previously reported14. Briefly, HEK293 cells were treated with 1 μ M apoA-I fibrils at 
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37 °C for 6 h followed by the LysoSensor (1 μ M, 3 min). Samples were examined with an LSM 710 confocal laser 
microscope according to the manufacturer’s instructions. Red signals indicated acidic conditions. For quantifica-
tion, images were analyzed by using ImageJ software.
Assessment of cytosolic release of cathepsin B. For subcellular fractionation into cytosolic and lysoso-
mal fractions, cells were treated with 1 μ M apoA-I fibrils at 37 °C for 6 h, washed 3 times with PBS and incubated 
with twice the volume of MSH buffer (210 mM mannitol, 70 mM sucrose, 20 mM HEPES, 1 mM EDTA, and a 
protease inhibitor cocktail, pH 7.5) at 4 °C for 45 min. Cells were lysed by using a 25-G needle and were then 
centrifuged for 5 min at 350 × g to precipitate nuclei. To obtain a crude membrane/lysosomal fraction, the post-
nuclear supernatant was centrifuged at 16,000 × g for 20 min followed by ultracentrifugation at 100,000 × g for 
45 min, and the pellet was resuspended in MSH buffer containing 1% Triton. The supernatant (cytosolic fraction) 
and lysosomal fraction were subjected to Western blotting with an anti-cathepsin B antibody as described above.
Statistical analysis. Data were analyzed via one-way analysis of variance, including the appropriate varia-
bles, followed by the Bonferroni test or unpaired Student’s t-test. Results were regarded as significant for p < 0.05.
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